Roche Valcyte Patent Ruled Valid, But Not Infringed
A judge has ruled that a Roche Palo Alto LLC patent used for the formulation of its anti-viral drug Valcyte is valid but that Ranbaxy Laboratories Ltd.'s generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article